Galderma Group AG
GALD
Company Profile
Business description
Galderma was formed in 1981 as a joint venture between Nestle and L’Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma’s science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.
Contact
Zahlerweg 10
Zug6300
CHET: +41 584558592
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,828.70 | 56.70 | 0.65% |
| CAC 40 | 7,738.42 | 75.83 | 0.99% |
| DAX 40 | 23,790.11 | 116.82 | 0.49% |
| Dow JONES (US) | 44,467.62 | 27.32 | -0.06% |
| FTSE 100 | 8,774.69 | 10.64 | -0.12% |
| HKSE | 24,221.41 | 149.13 | 0.62% |
| NASDAQ | 20,364.65 | 161.76 | 0.80% |
| Nikkei 225 | 39,762.48 | 223.85 | -0.56% |
| NZX 50 Index | 12,784.29 | 49.76 | 0.39% |
| S&P 500 | 6,221.04 | 23.03 | 0.37% |
| S&P/ASX 200 | 8,597.70 | 56.60 | 0.66% |
| SSE Composite Index | 3,454.79 | 2.95 | -0.09% |